MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03025aam a22004451i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
sulb0073236 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
BD-SySUS |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20200203111735.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m || d | |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr ||||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
171208s2018 flu o 000 0 eng d |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
|---|
| National bibliography number |
GBB921576 |
| Source |
bnb |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781315100470 |
| Qualifying information |
(e-book) |
|
|---|
| International Standard Book Number |
1315100479 |
|
|---|
| International Standard Book Number |
9781351586214 |
| Qualifying information |
(e-book ; |
| -- |
PDF) |
|
|---|
| International Standard Book Number |
1351586211 |
| 024 7# - OTHER STANDARD IDENTIFIER |
|---|
| Standard number or code |
10.1201/9781315100470 |
| Source of number or code |
doi |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(Uk)018842771 |
| 037 ## - SOURCE OF ACQUISITION |
|---|
| Stock number |
9781351586214 |
| Source of stock number/acquisition |
Ingram Content Group |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
CRCPR |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
CRCPR |
| Modifying agency |
OCLCQ |
| -- |
TYFRS |
| -- |
Uk |
| -- |
BD-SySUS |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
ukblsr |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS403 |
| Item number |
.D865 2018 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MED008000 |
| Source |
bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
23 |
| Item number |
DUM |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dunlap, Norma, |
| Relator term |
author. |
| 9 (RLIN) |
34258 |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Medicinal Chemistry / |
| Statement of responsibility, etc. |
editors, Huryn, Donna M. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Academic |
| 505 00 - FORMATTED CONTENTS NOTE |
|---|
| Title |
Part, I Drug Discovery and Development -- |
| -- |
chapter 1 Historical perspective and overview of drug discovery / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 2 Drug discovery: hit and lead identification / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 3 Lead optimization: drug-target interactions and the pharmacophore / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 4 Lead optimization: properties optimized and medicinal chemistry strategies / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 5 The process of developing a drug from an optimized lead / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
part, II Classes of Drug Targets -- |
| -- |
chapter 6 Receptors, ion channels, and transporters as drug targets / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 7 Enzymes as drug targets / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 8 Protein-protein and lipid structure interactions as drug targets / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 9 DNA and RNA as drug targets / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
part, III Selected Therapeutic Areas -- |
| -- |
chapter 10 Anti-cancer drugs / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 11 Antiviral and antifungal agents / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 12 Antibacterial and antiparasitic drugs / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter 13 Drugs acting on the central nervous system / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn -- |
| Title |
chapter Answers to End of Chapter Review Questions / |
| Statement of responsibility |
Norma Dunlap Donna M. Huryn. |
| 506 1# - RESTRICTIONS ON ACCESS NOTE |
|---|
| Terms governing access |
Legal Deposit; |
| Physical access provisions |
Only available on premises controlled by the deposit library and to one user at any one time; |
| Authorization |
The Legal Deposit Libraries (Non-Print Works) Regulations (UK). |
| Institution to which field applies |
UkOxU |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
|---|
| Terms governing use and reproduction |
Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force. |
| Institution to which field applies |
UkOxU |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Medicinal & Pharmaceutical Chemistry. |
| 9 (RLIN) |
34259 |
|
|---|
| Topical term or geographic name as entry element |
Pharmaceutical chemistry. |
| 9 (RLIN) |
34260 |
|
|---|
| Topical term or geographic name as entry element |
Chemotherapy. |
| 9 (RLIN) |
34261 |
| 655 #4 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books. |
| 9 (RLIN) |
34262 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Huryn, Donna M., |
| Relator term |
author. |
| 9 (RLIN) |
34263 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |
